Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
41.51
+0.38 (0.92%)
At close: Dec 20, 2024, 4:00 PM
41.50
-0.01 (-0.02%)
After-hours: Dec 20, 2024, 4:00 PM EST
Mirum Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -99.81 | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 | Upgrade
|
| Depreciation & Amortization | 24.2 | 11.45 | 3.68 | 0.98 | 0.62 | 0.32 | Upgrade
|
| Other Amortization | 1.64 | 1.12 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -108 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.73 | -1.73 | -1.7 | -0.14 | 0.07 | -0.33 | Upgrade
|
| Stock-Based Compensation | 44.91 | 35.02 | 27.01 | 23.09 | 12.55 | 6.07 | Upgrade
|
| Other Operating Activities | 16.15 | 69.25 | 7.59 | 18.32 | 0.34 | - | Upgrade
|
| Change in Accounts Receivable | -20.7 | -43.97 | -20.73 | - | - | - | Upgrade
|
| Change in Inventory | -5.14 | -4.39 | -3.45 | -0.5 | - | - | Upgrade
|
| Change in Accounts Payable | 43.5 | 30.78 | 7.64 | 22.66 | 3.68 | 10.06 | Upgrade
|
| Change in Other Net Operating Assets | -4.26 | -5.05 | -4.51 | -5.18 | -3.07 | -2.94 | Upgrade
|
| Operating Cash Flow | -1.23 | -70.94 | -120.14 | -132.76 | -89.08 | -39.36 | Upgrade
|
| Capital Expenditures | -0.97 | -0.11 | -0.28 | -0.02 | -0.23 | -0.28 | Upgrade
|
| Cash Acquisitions | - | -212.76 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -25 | -20 | - | -19 | - | - | Upgrade
|
| Investment in Securities | -66.79 | 125.67 | 7.98 | -40.43 | 38.1 | -127.5 | Upgrade
|
| Other Investing Activities | - | - | - | 108 | - | - | Upgrade
|
| Investing Cash Flow | -92.77 | -107.2 | 7.7 | 48.55 | 37.87 | -127.78 | Upgrade
|
| Long-Term Debt Issued | - | 305.3 | - | - | - | - | Upgrade
|
| Total Debt Issued | - | 305.3 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 305.3 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | 14.42 | 227.15 | 114.64 | 9.01 | 131.87 | 67.2 | Upgrade
|
| Other Financing Activities | -0.28 | -195.86 | -5.55 | 64.45 | 49.42 | - | Upgrade
|
| Financing Cash Flow | 14.14 | 336.6 | 109.09 | 73.47 | 181.29 | 127.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.19 | -0.13 | 0.01 | -0 | 0.03 | -0.03 | Upgrade
|
| Net Cash Flow | -79.67 | 158.32 | -3.34 | -10.75 | 130.12 | -39.99 | Upgrade
|
| Free Cash Flow | -2.2 | -71.05 | -120.41 | -132.78 | -89.3 | -39.64 | Upgrade
|
| Free Cash Flow Margin | -0.72% | -38.12% | -156.26% | -693.81% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -1.74 | -3.54 | -4.38 | -3.54 | -3.45 | Upgrade
|
| Cash Income Tax Paid | 0.77 | - | - | - | 0.01 | 0.02 | Upgrade
|
| Levered Free Cash Flow | -3.1 | -90.73 | -68.13 | -95.8 | -49.12 | -20.56 | Upgrade
|
| Unlevered Free Cash Flow | 4.19 | -82.41 | -58.14 | -84.81 | -48.91 | -20.56 | Upgrade
|
| Change in Net Working Capital | -21.03 | 40.55 | 6.54 | -18.54 | -3.32 | -7.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.